ERBB2 and cancer: Immunocompromised (NSG) mice were subcutaneously inoculated with HER2-expressing SKOV3 human cancer cells and then injected with RQR8+ HER2-CAR-expressing human donor CD8+ T cells, generated as shown in Figure 3A.